South Korea Contrast Media Market Size, Share, and COVID-19 Impact Analysis, By Type (Iodinated Contrast Media and Gadolinium-Based Contrast Media), By Form (Tablet, Powder, Liquid, and Paste), and South Korea Contrast Media Market Insights, Industry Trend, Forecasts to 2035

South Korea Contrast Media Market Insights Forecasts to 2035

• The South Korea Contrast Media Market Size was Estimated at USD 132.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 15.88% from 2025 to 2035
• The South Korea Contrast Media Market Size is Expected to Reach USD 672.04 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Contrast Media Market Size is Anticipated to Reach USD 672.04 Million by 2035, Growing at a CAGR of 15.88% from 2025 to 2035. Driven by the aging of the population and the rise in the incidence of long-term illnesses like cancer and heart disease. Market expansion is further accelerated by government expenditures on healthcare infrastructure and the uptake of high-resolution imaging technologies.

Market Overview

The market for contrast media in South Korea is the area of the medical imaging sector dedicated to the creation, manufacturing, and distribution of contrast agents that improve the visibility of internal body structures during diagnostic procedures. Additionally, increasing awareness of early illness detection and surveillance, particularly in the fields of cardiology and oncology, is driving the need for contrast agents. Government support for research and development, as well as collaboration between pharmaceutical and technology companies, can enable new product offerings that are tailored to local needs. High-quality, non-ionic contrast agents are gaining popularity because of their superior safety profile and reduced side effects. These contrast solutions are increasingly being used in South Korean clinics and hospitals in accordance with global best practices. Furthermore, because of the medical field's focus on sustainable practices, manufacturers are creating eco-friendly contrast media in response to environmental concerns. It is anticipated that South Korea will continue to innovate in the contrast media sector as patient safety and satisfaction gain importance in order to meet evolving healthcare demands.

Report Coverage

This research report categorizes the market for the South Korea contrast media market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea contrast media market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea contrast media market.

Driving Factors

The rising prevalence of chronic diseases like cancer and cardiovascular disorders is expected to drive significant growth in the South Korean contrast media market. According to the National Cancer Center of South Korea, the number of cancer diagnoses is expected to rise by about 4% annually, which will raise demand for contrast-media-based diagnostic imaging procedures. Furthermore, statistics indicate that approximately 30% of all deaths in South Korea are attributable to heart-related conditions, indicating that the prevalence of cardiovascular diseases is increasing. The market for contrast agents is directly impacted by the need for sophisticated imaging procedures like MRIs and CT scans, which necessitate efficient contrast media for best outcomes.

Restraining Factors

The market for contrast media in South Korea is constrained by the high expense of contrast agents and injectors, the possibility of negative reactions, and a lack of knowledge about sophisticated imaging methods. Further impeding domestic innovation and market expansion are regulatory barriers, reliance on imports, and the sluggish adoption of eco-friendly formulations.

Market Segmentation

The South Korea contrast media market share is classified into type and form.

• The iodinated contrast media segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea contrast media market is segmented by type into iodinated contrast media and gadolinium-based contrast media. Among these, the iodinated contrast media segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. In many imaging procedures, including computed tomography (CT) scans and angiographies, iodinated contrast media is crucial for the diagnosis of internal conditions and cardiovascular diseases. for its substantial contribution to diagnostic imaging, this segment has been widely accepted and used in South Korean healthcare facilities. The need for iodinated contrast agents is expected to increase steadily in South Korea due to the country's aging population, where older populations frequently need medical imaging.

• The liquid segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea contrast media market is segmented by form into tablet, powder, liquid, and paste. Among these, the liquid segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The liquid form is a popular option in many clinical settings because of its quick absorption and ease of administration.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea contrast media market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bracco Imaging Korea
• Nemoto Kyorindo Korea
• GE Healthcare Korea
• Bayer Korea Ltd.
• Guerbet Korea
• Others

Recent Developments:

• In April 2023, GE HealthCare unveiled Clariscan (gadoteric acid) and Pixxoscan (gadobutrol). Pixxoscan (gadobutrol) was a macrocyclic, non-ionic gadolinium-based contrast agent (GBCA) for Magnetic Resonance Imaging (MRI), thereby broadened its portfolio of MRI contrast agents.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Contrast Media Market based on the below-mentioned segments:

South Korea Contrast Media Market, By Type

• Iodinated Contrast Media
• Gadolinium-Based Contrast Media

South Korea Contrast Media Market, By Form

• Tablet
• Powder
• Liquid
• Paste